Edgewood Management’s AbbVie ABBV Stock Holding History

Edgewood Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.5M	Hold	45,542	–	–	0.12%	26
2026 Q1	$9.9M	Sell	45,542 -10,872	-19%	-$2.41M	0.06%	25
2025 Q4	$12.9M	Sell	56,414 -9,000	-14%	-$2.05M	0.06%	26
2025 Q3	$15.1M	Sell	65,414 -4,829	-7%	-$983K	0.05%	26
2025 Q2	$13M	Hold	70,243	–	–	0.04%	27
2025 Q1	$14.7M	Sell	70,243 -6,000	-8%	-$1.17M	0.05%	27
2024 Q4	$13.5M	Hold	76,243	–	–	0.04%	27
2024 Q3	$15.1M	Sell	76,243 -4,116	-5%	-$768K	0.04%	27
2024 Q2	$13.8M	Sell	80,359 -171	-0.2%	-$28.3K	0.04%	28
2024 Q1	$14.7M	Hold	80,530	–	–	0.04%	28
2023 Q4	$12.5M	Hold	80,530	–	–	0.04%	27
2023 Q3	$12M	Sell	80,530 -200	-0.2%	-$29.4K	0.04%	28
2023 Q2	$10.9M	Hold	80,730	–	–	0.03%	27
2023 Q1	$12.9M	Hold	80,730	–	–	0.04%	28
2022 Q4	$13M	Hold	80,730	–	–	0.05%	29
2022 Q3	$10.8M	Hold	80,730	–	–	0.04%	27
2022 Q2	$12.4M	Hold	80,730	–	–	0.04%	29
2022 Q1	$13.1M	Hold	80,730	–	–	0.03%	27
2021 Q4	$10.9M	Hold	80,730	–	–	0.02%	28
2021 Q3	$8.71M	Buy	80,730 +250	+0.3%	+$28.6K	0.01%	28
2021 Q2	$9.06M	Hold	80,480	–	–	0.02%	28
2021 Q1	$8.71M	Hold	80,480	–	–	0.02%	29
2020 Q4	$8.62M	Hold	80,480	–	–	0.02%	28
2020 Q3	$7.05M	Buy	80,480 +900	+1%	+$84.7K	0.02%	30
2020 Q2	$7.81M	Hold	79,580	–	–	0.02%	29
2020 Q1	$6.06M	Hold	79,580	–	–	0.02%	31
2019 Q4	$7.05M	Buy	79,580 +2,050	+3%	+$170K	0.02%	30
2019 Q3	$5.87M	Hold	77,530	–	–	0.02%	31
2019 Q2	$5.64M	Hold	77,530	–	–	0.02%	31
2019 Q1	$6.25M	Hold	77,530	–	–	0.02%	31
2018 Q4	$7.15M	Hold	77,530	–	–	0.03%	29
2018 Q3	$7.33M	Hold	77,530	–	–	0.02%	28
2018 Q2	$7.18M	Sell	77,530 -1,000	-1%	-$97.7K	0.03%	27
2018 Q1	$7.43M	Hold	78,530	–	–	0.03%	27
2017 Q4	$7.59M	Sell	78,530 -1,100	-1%	-$104K	0.03%	28
2017 Q3	$7.08M	Sell	79,630 -4,057	-5%	-$309K	0.03%	27
2017 Q2	$6.07M	Hold	83,687	–	–	0.03%	29
2017 Q1	$5.45M	Sell	83,687 -1,975	-2%	-$124K	0.03%	30
2016 Q4	$5.36M	Sell	85,662 -1,000	-1%	-$61K	0.04%	32
2016 Q3	$5.47M	Sell	86,662 -2,000	-2%	-$129K	0.04%	31
2016 Q2	$5.49M	Sell	88,662 -1,100	-1%	-$67K	0.04%	31
2016 Q1	$5.13M	Sell	89,762 -4,000	-4%	-$223K	0.04%	31
2015 Q4	$5.55M	Sell	93,762 -4,911	-5%	-$283K	0.04%	31
2015 Q3	$5.37M	Hold	98,673	–	–	0.05%	30
2015 Q2	$6.63M	Sell	98,673 -1,723	-2%	-$112K	0.06%	27
2015 Q1	$5.88M	Sell	100,396 -10,800	-10%	-$652K	0.05%	33
2014 Q4	$7.28M	Hold	111,196	–	–	0.07%	30
2014 Q3	$6.42M	Hold	111,196	–	–	0.06%	32
2014 Q2	$6.28M	Hold	111,196	–	–	0.06%	33
2014 Q1	$5.71M	Hold	111,196	–	–	0.06%	33
2013 Q4	$5.87M	Hold	111,196	–	–	0.07%	32
2013 Q3	$4.97M	Sell	111,196 -866	-0.8%	-$38.4K	0.06%	32
2013 Q2	$4.63M	Buy	+112,062	New	+$4.9M	0.06%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Edgewood Management's ABBV Position: Q2 2026 in Review

Edgewood Management held its AbbVie (ABBV) position steady in Q2 2026 at 45,542 shares worth $11.5M. The position accounts for 0.12% of the portfolio, ranked #26.

Edgewood Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.1M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Edgewood Management held 45,542 shares of AbbVie worth $11.5M as of Q2 2026.
Edgewood Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.12% of Edgewood Management's portfolio in Q2 2026, its #26 holding.
Edgewood Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Edgewood Management's AbbVie position peaked at $15.1M in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.